Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RANIBIZUMAB-EQRN: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

75.0%
Female
25.0%
Male

Age Information

The average age of patients reporting adverse events with RANIBIZUMAB-EQRN is 85.6 years.

Geographic Distribution

The majority of adverse event reports for RANIBIZUMAB-EQRN originate from US.

Report Summary & Outcomes

97
Total Reports
97
As Primary/Secondary Suspect
6
Deaths Reported
0
Hospitalizations

Reporting Timeline

First adverse event report: 20230426. Most recent report: 20250107. View full timeline →

More About RANIBIZUMAB-EQRN

RANIBIZUMAB-EQRN Full Profile Reports by Year Drug Interactions